Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYTARABINE Cause Secondary immunodeficiency? 250 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 250 reports of Secondary immunodeficiency have been filed in association with CYTARABINE (cytarabine). This represents 0.6% of all adverse event reports for CYTARABINE.

250
Reports of Secondary immunodeficiency with CYTARABINE
0.6%
of all CYTARABINE reports
224
Deaths
4
Hospitalizations

How Dangerous Is Secondary immunodeficiency From CYTARABINE?

Of the 250 reports, 224 (89.6%) resulted in death, 4 (1.6%) required hospitalization, and 2 (0.8%) were considered life-threatening.

Is Secondary immunodeficiency Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CYTARABINE. However, 250 reports have been filed with the FAERS database.

What Other Side Effects Does CYTARABINE Cause?

Febrile neutropenia (6,142) Off label use (4,183) Pyrexia (2,992) Neutropenia (2,558) Disease progression (2,352) Drug ineffective (2,281) Thrombocytopenia (2,148) Sepsis (2,013) Myelosuppression (1,869) Product use in unapproved indication (1,619)

What Other Drugs Cause Secondary immunodeficiency?

PREDNISONE (402) CYCLOPHOSPHAMIDE (362) VINCRISTINE (331) DEXAMETHASONE (282) METHOTREXATE (280) METHYLPREDNISOLONE (255) MERCAPTOPURINE (241) DAUNORUBICIN (240) ETOPOSIDE (240) ASPARAGINASE (233)

Which CYTARABINE Alternatives Have Lower Secondary immunodeficiency Risk?

CYTARABINE vs CYTARABINE\DAUNORUBICIN CYTARABINE vs DABIGATRAN CYTARABINE vs DABIGATRAN ETEXILATE CYTARABINE vs DABRAFENIB CYTARABINE vs DABRAFENIB\TRAMETINIB

Related Pages

CYTARABINE Full Profile All Secondary immunodeficiency Reports All Drugs Causing Secondary immunodeficiency CYTARABINE Demographics